Li T - Search Results

1

Combination of PD-1 blockade and RetroNectin^®-activated cytokine-induced killer in preheavily treated non-small-cell lung cancer: a retrospective study.

Zhao L, Han L, Zhang Y, Li T, Yang Y, Li W, Shang Y, Lin H, Gao Q. Zhao L, et al. Among authors: li t, li w. Immunotherapy. 2018 Nov;10(15):1315-1323. doi: 10.2217/imt-2018-0125. Epub 2018 Oct 23. Immunotherapy. 2018. PMID: 30350739

2

Circulating and tumor-infiltrating Tim-3 in patients with colorectal cancer.

Xu B, Yuan L, Gao Q, Yuan P, Zhao P, Yuan H, Fan H, Li T, Qin P, Han L, Fang W, Suo Z. Xu B, et al. Among authors: li t. Oncotarget. 2015 Aug 21;6(24):20592-603. doi: 10.18632/oncotarget.4112. Oncotarget. 2015. PMID: 26008981 Free PMC article.

3

TGFβ1-induced down-regulation of microRNA-138 contributes to epithelial-mesenchymal transition in primary lung cancer cells.

Zhang F, Li T, Han L, Qin P, Wu Z, Xu B, Gao Q, Song Y. Zhang F, et al. Among authors: li t. Biochem Biophys Res Commun. 2018 Feb 19;496(4):1169-1175. doi: 10.1016/j.bbrc.2018.01.164. Epub 2018 Jan 31. Biochem Biophys Res Commun. 2018. PMID: 29407170

4

Nivolumab-induced cytokine-release syndrome in relapsed/refractory Hodgkin's lymphoma: a case report and literature review.

Zhao L, Yang Y, Li W, Li T, Gao Q. Zhao L, et al. Among authors: li t, li w. Immunotherapy. 2018 Aug;10(11):913-917. doi: 10.2217/imt-2018-0025. Immunotherapy. 2018. PMID: 30149764 Review.

5

Clinical value of neutrophil-to-lymphocyte ratio as a predictor of prognosis of RetroNectin^®-activated cytokine-induced killer cell therapy in advanced non-small-cell lung cancer.

Zhao L, Li T, Yang Y, Zhang Y, Li W, Han L, Shang Y, Lin H, Ren X, Gao Q. Zhao L, et al. Among authors: li t, li w. Immunotherapy. 2019 Mar;11(4):273-282. doi: 10.2217/imt-2018-0147. Epub 2018 Dec 14. Immunotherapy. 2019. PMID: 30547699

6

Exploring a Tumor-Intrinsic PD-L1 Signal with Proximity-Dependent Biotin Identification in Lung Cancer Cells.

Li T, Zhang F, Qin P, Wang Y, Wang A, Zhao L, Xu B, Gao Q. Li T, et al. Biochemistry. 2019 May 7;58(18):2293-2296. doi: 10.1021/acs.biochem.9b00113. Epub 2019 Apr 26. Biochemistry. 2019. PMID: 31021072

7

Pseudoprogression: an indicator for cure in combined immunotherapy?

Zhao L, Yang Y, Li W, Li T, Han L, Lin H, Gao Q. Zhao L, et al. Among authors: li t, li w. Immunotherapy. 2019 Sep;11(13):1087-1093. doi: 10.2217/imt-2019-0034. Epub 2019 Jul 30. Immunotherapy. 2019. PMID: 31361166

8

Factors Influencing the Efficacy of Anti-PD-1 Therapy in Chinese Patients with Advanced Melanoma.

Zhao L, Yang Y, Ma B, Li W, Li T, Han L, Zhang Y, Shang YM, Lin H, Gao Q. Zhao L, et al. Among authors: li t, li w. J Oncol. 2019 Sep 26;2019:6454989. doi: 10.1155/2019/6454989. eCollection 2019. J Oncol. 2019. PMID: 31662753 Free PMC article.

9

S-15 in combination of Akt inhibitor promotes the expansion of CD45RA^-CCR7⁺ tumor infiltrating lymphocytes with high cytotoxic potential and downregulating PD-1⁺Tim-3⁺ cells as well as regulatory T cells.

Xu B, Yuan L, Chen G, Li T, Zhou J, Zhang C, Qin P, Muthana MM, Wang S, Du X, Gao Q. Xu B, et al. Among authors: li t. Cancer Cell Int. 2019 Dec 3;19:322. doi: 10.1186/s12935-019-1043-3. eCollection 2019. Cancer Cell Int. 2019. PMID: 31827396 Free PMC article.

10

Chemotherapy Reverses Anti-PD-1 Resistance in One Patient With Advanced Non-small Lung Cell Cancer.

Zhao L, Ma B, Yang Y, Li T, Han L, Gao Q. Zhao L, et al. Among authors: li t. Front Oncol. 2020 Apr 21;10:507. doi: 10.3389/fonc.2020.00507. eCollection 2020. Front Oncol. 2020. PMID: 32373522 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

39,428 results

Search Page

Filters